Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02331498
Title Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme (PAZOGLIO)
Acronym PAZOGLIO
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Centre Antoine Lacassagne
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Antoine Lacassagne RECRUITING Nice Cedex 2 06189 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field